vs
NEOGEN CORP（NEOG）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
NEOGEN CORP的季度营收约是Resolute Holdings Management, Inc.的1.9倍（$224.7M vs $117.7M），Resolute Holdings Management, Inc.净利率更高（-1.5% vs -7.1%，领先5.6%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $7.8M）
Neogen Corporation是一家1982年成立、总部位于美国密歇根州兰辛的跨国食品安全企业，专注提供各类检测试剂盒及相关产品，用于筛查食品中的有害成分。目前业务覆盖美国、加拿大、英国、欧洲部分地区、墨西哥、巴西、印度、中国等多个国家，旗下拥有超100款药物检测试剂盒产品，可检测约300种相关违禁物质。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
NEOG vs RHLD — 直观对比
营收规模更大
NEOG
是对方的1.9倍
$117.7M
净利率更高
RHLD
高出5.6%
-7.1%
自由现金流更多
RHLD
多$181.5M
$7.8M
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $224.7M | $117.7M |
| 净利润 | $-15.9M | $-1.7M |
| 毛利率 | 47.5% | 55.7% |
| 营业利润率 | -2.4% | 30.2% |
| 净利率 | -7.1% | -1.5% |
| 营收同比 | -2.8% | — |
| 净利润同比 | 96.5% | — |
| 每股收益（稀释后） | $-0.07 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEOGRHLD
| Q4 25 | $224.7M | $117.7M | ||
| Q3 25 | $209.2M | $120.9M | ||
| Q2 25 | $225.4M | $119.6M | ||
| Q1 25 | $221.0M | $103.9M | ||
| Q4 24 | $231.3M | — | ||
| Q3 24 | $217.0M | — | ||
| Q2 24 | $236.8M | — | ||
| Q1 24 | $228.8M | — |
净利润NEOGRHLD
| Q4 25 | $-15.9M | $-1.7M | ||
| Q3 25 | $36.3M | $-231.0K | ||
| Q2 25 | $-612.3M | $-611.0K | ||
| Q1 25 | $-10.9M | $-3.4M | ||
| Q4 24 | $-456.3M | — | ||
| Q3 24 | $-12.6M | — | ||
| Q2 24 | $-5.4M | — | ||
| Q1 24 | $-2.0M | — |
毛利率NEOGRHLD
| Q4 25 | 47.5% | 55.7% | ||
| Q3 25 | 45.4% | 59.0% | ||
| Q2 25 | 41.2% | 57.5% | ||
| Q1 25 | 49.9% | 52.5% | ||
| Q4 24 | 49.0% | — | ||
| Q3 24 | 48.4% | — | ||
| Q2 24 | 47.9% | — | ||
| Q1 24 | 51.1% | — |
营业利润率NEOGRHLD
| Q4 25 | -2.4% | 30.2% | ||
| Q3 25 | -7.7% | 34.3% | ||
| Q2 25 | -271.1% | 34.0% | ||
| Q1 25 | 2.4% | 24.7% | ||
| Q4 24 | -197.8% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 5.3% | — |
净利率NEOGRHLD
| Q4 25 | -7.1% | -1.5% | ||
| Q3 25 | 17.4% | -0.2% | ||
| Q2 25 | -271.6% | -0.5% | ||
| Q1 25 | -4.9% | -3.2% | ||
| Q4 24 | -197.3% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | -2.3% | — | ||
| Q1 24 | -0.9% | — |
每股收益（稀释后）NEOGRHLD
| Q4 25 | $-0.07 | $-0.20 | ||
| Q3 25 | $0.17 | $-0.03 | ||
| Q2 25 | $-2.82 | $-0.07 | ||
| Q1 25 | $-0.05 | $-0.39 | ||
| Q4 24 | $-2.10 | — | ||
| Q3 24 | $-0.06 | — | ||
| Q2 24 | $-0.02 | — | ||
| Q1 24 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.3M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $2.1B | $6.5M |
| 总资产 | $3.4B | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资NEOGRHLD
| Q4 25 | $145.3M | $205.5M | ||
| Q3 25 | $138.9M | $148.0M | ||
| Q2 25 | $129.0M | $99.9M | ||
| Q1 25 | $127.7M | $71.0M | ||
| Q4 24 | $140.2M | — | ||
| Q3 24 | $120.5M | — | ||
| Q2 24 | $170.9M | — | ||
| Q1 24 | $168.4M | — |
总债务NEOGRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NEOGRHLD
| Q4 25 | $2.1B | $6.5M | ||
| Q3 25 | $2.1B | $10.8M | ||
| Q2 25 | $2.1B | $9.6M | ||
| Q1 25 | $2.7B | $8.9M | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.1B | — | ||
| Q1 24 | $3.1B | — |
总资产NEOGRHLD
| Q4 25 | $3.4B | $333.4M | ||
| Q3 25 | $3.4B | $293.2M | ||
| Q2 25 | $3.4B | $253.3M | ||
| Q1 25 | $4.0B | $214.3M | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.5B | — | ||
| Q2 24 | $4.5B | — | ||
| Q1 24 | $4.6B | — |
负债/权益比NEOGRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $7.8M | $189.2M |
| 自由现金流率自由现金流/营收 | 3.5% | 160.8% |
| 资本支出强度资本支出/营收 | 5.2% | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-18.5M | $313.2M |
8季度趋势，按日历期对齐
经营现金流NEOGRHLD
| Q4 25 | $19.4M | $196.1M | ||
| Q3 25 | $10.9M | $59.6M | ||
| Q2 25 | $16.4M | $48.9M | ||
| Q1 25 | $19.5M | $18.4M | ||
| Q4 24 | $40.3M | — | ||
| Q3 24 | $-17.9M | — | ||
| Q2 24 | $26.7M | — | ||
| Q1 24 | $-30.2M | — |
自由现金流NEOGRHLD
| Q4 25 | $7.8M | $189.2M | ||
| Q3 25 | $-13.1M | $58.6M | ||
| Q2 25 | $349.0K | $47.5M | ||
| Q1 25 | $-13.4M | $17.8M | ||
| Q4 24 | $23.1M | — | ||
| Q3 24 | $-56.3M | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $-62.3M | — |
自由现金流率NEOGRHLD
| Q4 25 | 3.5% | 160.8% | ||
| Q3 25 | -6.3% | 48.5% | ||
| Q2 25 | 0.2% | 39.7% | ||
| Q1 25 | -6.1% | 17.1% | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | -26.0% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | -27.2% | — |
资本支出强度NEOGRHLD
| Q4 25 | 5.2% | 5.8% | ||
| Q3 25 | 11.5% | 0.8% | ||
| Q2 25 | 7.1% | 1.2% | ||
| Q1 25 | 14.9% | 0.6% | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 17.7% | — | ||
| Q2 24 | 10.2% | — | ||
| Q1 24 | 14.0% | — |
现金转化率NEOGRHLD
| Q4 25 | — | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEOG
| Other | $109.2M | 49% |
| Bacterial And General Sanitation | $44.9M | 20% |
| Services | $25.7M | 11% |
| Natural Toxins And Allergens | $20.4M | 9% |
| Animal Care | $8.9M | 4% |
| Genomics Services | $6.3M | 3% |
| Biosecurity Products | $4.6M | 2% |
| Life Sciences | $1.4M | 1% |
RHLD
暂无分部数据
